Cervical cancer screening with HPV testing in Colombia
- Routine care
Cervical cancer grows slowly from a known virus, so screening can almost eliminate it. Women still die of it mostly because they were never screened.
See it in 3D: Cervix · Vaginal fornix
What it is
Almost all cervical cancer is caused by persistent infection with high-risk human papillomavirus (HPV), mainly types 16 and 18. The virus causes precancerous changes (cervical intraepithelial neoplasia, CIN) that take 10 to 20 years to become cancer, which leaves a long window to find and treat them. Screening looks either for the cause (an HPV DNA test) or for the damage (cytology, or visual inspection with acetic acid and Lugol's iodine). In Colombia, Resolución 3280 de 2018 sets cytology every 3 years (after an initial pair of yearly tests) for women aged 25 to 29, primary HPV testing every 5 years from 30 to 65, and visual inspection with immediate treatment ('see and treat') for women aged 30 to 50 in areas with poor access. WHO's elimination strategy adds HPV vaccination of girls and treatment of every lesion found.
What it looks for
- 25 to 29 years: cytology on the 1-3-3 schedule (one cytology, then every 3 years while results are negative).
- 30 to 65 years: HPV DNA test every 5 years if negative; a positive test is triaged with cytology (and genotyping where available), and abnormal results go to colposcopy.
- Hard-to-reach areas, 30 to 50 years: visual inspection with acetic acid and Lugol's iodine, and cryotherapy or thermal ablation in the same visit when eligible.
- Women with HIV start earlier and are screened more often (WHO).
- Vaccinated women still need screening: vaccines do not cover every high-risk type.
- Self-sampling: a woman can take her own vaginal swab for the HPV test; it reaches women who avoid or cannot reach a speculum examination (WHO).
How it is done
- High-risk HPV infects the transformation zone of the cervix, usually soon after sexual debut.
- Most infections clear within 1 to 2 years; a minority persist.
- Persistent virus makes the E6 and E7 proteins, which disable the p53 and Rb tumour suppressors.
- Cells accumulate damage: low-grade lesions (often regress), then high-grade lesions (CIN 2–3).
- Untreated high-grade lesions can invade over years: cervical cancer.
- Screening finds lesions at the high-grade stage, when removing the transformation zone cures them.
Screening tests compared
| Test | Looks for | Strength | Limitation |
|---|---|---|---|
| HPV DNA test | The cause (high-risk HPV) | Most sensitive; negative result safe for 5 years; can be self-sampled | Many positives clear alone: needs triage |
| Cytology (Papanicolaou) | Abnormal cells | Specific; triages HPV-positive women | Less sensitive; needs a laboratory and repeat testing |
| Visual inspection (acetic acid, Lugol) | White or iodine-negative areas | Cheap; result at once; allows see-and-treat | Less accurate; less useful after menopause |
| Colposcopy with biopsy | Diagnosis of the lesion | Confirms grade and guides treatment | Not a screening test |
Common mistakes
- Screening women under 25 finds many lesions that would regress and leads to overtreatment that can weaken the cervix in later pregnancies.
- Postcoital or intermenstrual bleeding is not a screening question: examine the cervix and refer if it looks abnormal, whatever the last test showed.
- Women who had a hysterectomy for benign disease with the cervix removed no longer need screening.
- Excision chain: a deeper or repeated cone removes more cervix → a shorter, weaker cervix → more preterm birth and mid-trimester loss later; treat only what needs treating and tell her obstetrician.
- HPV also causes vaginal and vulvar precancer (VaIN, VIN): look at the vagina and vulva at colposcopy; a persistent itchy, raised or discoloured vulvar patch needs a biopsy.
Next step / When to refer
- HPV-negative: repeat in 5 years. HPV-positive with normal triage: repeat HPV testing in about a year as the route sets.
- HPV-positive with abnormal triage, or high-grade cytology: refer to colposcopy and biopsy.
- CIN 2–3: ablation (thermal or cryotherapy) if the whole lesion and transformation zone are visible and no cancer is suspected; otherwise loop excision (LLETZ).
- Refer every visible cervical lesion or suspected cancer to gynaecological oncology without waiting for screening results.
- Test of cure: an HPV test about a year after treatment; return to routine screening only after a negative result.
Common traps
- Telling an HPV-positive woman she has cancer, or will get it: most infections clear, and the result means closer follow-up.
- Screening adolescents and young women under 25: it causes harm without saving lives.
- Stopping screening because she was vaccinated: vaccines prevent most, not all, cervical cancers.
- Reassuring a woman with a visible cervical mass because her last smear was normal: symptoms need examination, not screening.
- A hysterectomy ends screening for everyone: after hysterectomy for CIN 2+ or cancer, vaginal vault testing continues because VaIN can follow.
Test yourself
Think of the answer, then tap the question to see it.
Why can a negative HPV test safely be repeated after 5 years, while normal cytology is repeated after 3?
The HPV test detects the cause and is more sensitive, so a negative result predicts a very low risk of high-grade disease for longer.
A 34-year-old has a positive HPV test and normal cytology. What happens next?
She does not need treatment; the HPV test is repeated in about a year (as the route sets), and colposcopy follows if it stays positive or triage is abnormal.
How do the HPV proteins E6 and E7 cause cancer?
E6 promotes breakdown of p53 and E7 inactivates Rb, removing two key brakes on the cell cycle so damaged cells keep dividing.
Elsewhere in DurgiPedia
- Screening in women's health: cervical cancer, breast cancer and the Res. 3280 schedule
- Taking a cervical cytology or HPV sample and assisting the pelvic examination
- Cervical cancer screening and prevention
- HPV and cervical carcinogenesis
- Cervical squamous intraepithelial lesions (LSIL, HSIL)
Connections
See it in 3D2
The structures of Durgical's 3D anatomy where it is found.
Microorganisms1
In Pharmacology1
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (World Health Organization, 2021); Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud y de la Ruta Materno Perinatal (Ministerio de Salud y Protección Social de Colombia, 2018); Cervical Cancer Screening (PDQ®), health professional version (National Cancer Institute (US), 2025); Abnormal Papanicolaou Smear (StatPearls Publishing (NCBI Bookshelf), 2026); Colposcopy (StatPearls Publishing (NCBI Bookshelf), 2023); Vulvar Intraepithelial Neoplasia (StatPearls (NCBI Bookshelf), 2023); Cold Knife Conization of the Cervix (StatPearls Publishing (NCBI Bookshelf), 2023); Cáncer de cuello uterino (screening schedules: cytology 1-3-3 at 25–29, HPV DNA 1-5-5 at 30–65; Res. 3280 de 2018 as amended by Res. 276 de 2019) (Ministerio de Salud y Protección Social (Colombia), 2019).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
